DOI QR코드

DOI QR Code

Long noncoding RNA involvement in cancer

  • Maruyama, Reo ;
  • Suzuki, Hiromu
  • Received : 2012.10.10
  • Published : 2012.11.30

Abstract

Recent advances in genome and transcriptome analysis have enabled identification of numerous members of a new class of noncoding RNA, long noncoding RNA (lncRNA). lncRNAs are broadly defined as RNA molecules greater than 200 nt in length and lacking an open reading frame. Recent studies provide evidence that lncRNAs play central roles in a wide range of cellular processes through interaction with key component proteins in the gene regulatory system, and that alteration of their cell- or tissue-specific expression and/or their primary or secondary structures is thought to promote cell proliferation, invasion and metastasis. The biological and molecular characteristics of the large majority of lncRNAs remains unknown, and it is anticipated that improved understanding of the roles played by lncRNAs in cancer will lead to the development of novel biomarkers and effective therapeutic strategies.

Keywords

Biomarker;Cancer;Gene regulation;Histone modification;LincRNA;Long noncoding RNA;Oncogene;Tumor suppressor

References

  1. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874.
  2. Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A. and Rinn, J. L. (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915-1927. https://doi.org/10.1101/gad.17446611
  3. Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F. and Mattick, J. S. (2008) Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 105, 716-721. https://doi.org/10.1073/pnas.0706729105
  4. Hung, T., Wang, Y., Lin, M. F., Koegel, A. K., Kotake, Y., Grant, G. D., Horlings, H. M., Shah, N., Umbricht, C., Wang, P., Kong, B., Langerod, A., Borresen-Dale, A. L., Kim, S. K., van de Vijver, M., Sukumar, S., Whitfield, M. L., Kellis, M., Xiong, Y., Wong, D. J. and Chang, H. Y. (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 43, 621-629. https://doi.org/10.1038/ng.848
  5. Gutschner, T. and Diederichs, S. (2012) The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol. 9, 703-719. doi: 10.4161/rna.20481. https://doi.org/10.4161/rna.20481
  6. Wang, K. C. and Chang, H. Y. (2011) Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904-914. https://doi.org/10.1016/j.molcel.2011.08.018
  7. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. and Lee, J. T. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756. https://doi.org/10.1126/science.1163045
  8. Nagano, T., Mitchell, J. A., Sanz, L. A., Pauler, F. M., Ferguson-Smith, A. C., Feil, R. and Fraser, P. (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322, 1717-1720. https://doi.org/10.1126/science.1163802
  9. Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces- Zimmerman, R., Chen, Y., Lajoie, B. R., Protacio, A., Flynn, R. A., Gupta, R. A., Wysocka, J., Lei, M., Dekker, J., Helms, J. A. and Chang, H. Y. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124. https://doi.org/10.1038/nature09819
  10. Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T. and Rinn, J. L. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419. https://doi.org/10.1016/j.cell.2010.06.040
  11. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R. B., van de Vijver, M. J., Sukumar, S. and Chang, H. Y. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. https://doi.org/10.1038/nature08975
  12. Niland, C. N., Merry, C. R. and Khalil, A. M. (2012) Emerging roles for long non-coding rnas in cancer and neurological disorders. Front Genet. 3, 25.
  13. Chu, C., Qu, K., Zhong, F. L., Artandi, S. E. and Chang, H. Y. (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 44, 667-678. https://doi.org/10.1016/j.molcel.2011.08.027
  14. Yap, K. L., Li, S., Munoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J. and Zhou, M. M. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674. https://doi.org/10.1016/j.molcel.2010.03.021
  15. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M. and Xiong, Y. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30, 1956-1962. https://doi.org/10.1038/onc.2010.568
  16. Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., Nagano, T., Mancini-Dinardo, D. and Kanduri, C. (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32, 232-246. https://doi.org/10.1016/j.molcel.2008.08.022
  17. A. W., Fox, A. H., Chess, A. and Lawrence, J. B. (2009) An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 33, 717-726. https://doi.org/10.1016/j.molcel.2009.01.026
  18. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E. and Chang, H. Y. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693. https://doi.org/10.1126/science.1192002
  19. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., Regev, A., Lander, E. S. and Rinn, J. L. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 11667-11672. https://doi.org/10.1073/pnas.0904715106
  20. Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., Yang, X., Amit, I., Meissner, A., Regev, A., Rinn, J. L., Root, D. E. and Lander, E. S. (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300. https://doi.org/10.1038/nature10398
  21. Kino, T., Hurt, D. E., Ichijo, T., Nader, N. and Chrousos, G. P. (2010) Noncoding RNA gas5 is a growth arrest- and starvation- associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8. https://doi.org/10.1126/scisignal.2000568
  22. Redon, S., Reichenbach, P. and Lingner, J. (2010) The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 38, 5797-5806. https://doi.org/10.1093/nar/gkq296
  23. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J. and Pandolfi, P. P. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038. https://doi.org/10.1038/nature09144
  24. Song, M. S., Carracedo, A., Salmena, L., Song, S. J., Egia, A., Malumbres, M. and Pandolfi, P. P. (2011) Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144, 187-199. https://doi.org/10.1016/j.cell.2010.12.020
  25. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E. and Chang, H. Y. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323. https://doi.org/10.1016/j.cell.2007.05.022
  26. Yang, Z., Zhou, L., Wu, L. M., Lai, M. C., Xie, H. Y., Zhang, F. and Zheng, S. S. (2011) Overexpression of long non-coding rna hotair predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18, 1243-1250. https://doi.org/10.1245/s10434-011-1581-y
  27. Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., Miyano, S. and Mori, M. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320-6326. https://doi.org/10.1158/0008-5472.CAN-11-1021
  28. Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S. and Safe, S. (2012) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene [Epub ahead of print].
  29. Niinuma, T., Suzuki, H., Nojima, M., Nosho, K., Yamamoto, H., Takamaru, H., Yamamoto, E., Maruyama, R., Nobuoka, T., Miyazaki, Y., Nishida, T., Bamba, T., Kanda, T., Ajioka, Y., Taguchi, T., Okahara, S., Takahashi, H., Nishida, Y., Hosokawa, M., Hasegawa, T., Tokino, T., Hirata, K., Imai, K., Toyota, M. and Shinomura, Y. (2012) Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 72, 1126-1136. https://doi.org/10.1158/0008-5472.CAN-11-1803
  30. Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D. and Bieche, I. (2007) Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969. https://doi.org/10.1158/0008-5472.CAN-06-2004
  31. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P. and Cui, H. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206. https://doi.org/10.1038/nature06468
  32. Popov, N. and Gil, J. (2010) Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 5, 685-690. https://doi.org/10.4161/epi.5.8.12996
  33. Iacobucci, I., Sazzini, M., Garagnani, P., Ferrari, A., Boattini, A., Lonetti, A., Papayannidis, C., Mantovani, V., Marasco, E., Ottaviani, E., Soverini, S., Girelli, D., Luiselli, D., Vignetti, M., Baccarani, M. and Martinelli, G. (2011) A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk. Res. 35, 1052-1059. https://doi.org/10.1016/j.leukres.2011.02.020
  34. Pasmant, E., Sabbagh, A., Masliah-Planchon, J., Ortonne, N., Laurendeau, I., Melin, L., Ferkal, S., Hernandez, L., Leroy, K., Valeyrie-Allanore, L., Parfait, B., Vidaud, D., Bieche, I., Lantieri, L., Wolkenstein, P. and Vidaud, M. (2011) Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J. Natl. Cancer Inst. 103, 1713-1722. https://doi.org/10.1093/jnci/djr416
  35. Pasmant, E., Sabbagh, A., Vidaud, M. and Bieche, I. (2011) ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444-448. https://doi.org/10.1096/fj.10-172452
  36. Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., Thomas, M., Berdel, W. E., Serve, H. and Muller-Tidow, C. (2003) MALAT-1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. https://doi.org/10.1038/sj.onc.1206928
  37. Yamada, K., Kano, J., Tsunoda, H., Yoshikawa, H., Okubo, C., Ishiyama, T. and Noguchi, M. (2006) Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci. 97, 106-112. https://doi.org/10.1111/j.1349-7006.2006.00147.x
  38. Lin, R., Maeda, S., Liu, C., Karin, M. and Edgington, T. S. (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26, 851-858. https://doi.org/10.1038/sj.onc.1209846
  39. Muller-Tidow, C., Diederichs, S., Thomas, M. and Serve, H. (2004) Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer. Lung Cancer 45(Suppl 2), S145-150. https://doi.org/10.1016/j.lungcan.2004.07.979
  40. Tano, K., Mizuno, R., Okada, T., Rakwal, R., Shibato, J., Masuo, Y., Ijiri, K. and Akimitsu, N. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575-4580. https://doi.org/10.1016/j.febslet.2010.10.008
  41. Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., Blencowe, B. J., Prasanth, S. G. and Prasanth, K. V. (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938. https://doi.org/10.1016/j.molcel.2010.08.011
  42. Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., Cao, X., Jing, X., Wang, X., Siddiqui, J., Wei, J. T., Robinson, D., Iyer, H. K., Palanisamy, N., Maher, C. A. and Chinnaiyan, A. M. (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29, 742-749. https://doi.org/10.1038/nbt.1914
  43. Schneider, C., King, R. M. and Philipson, L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787-793. https://doi.org/10.1016/S0092-8674(88)91065-3
  44. Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F. and Williams, G. T. (2009) GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195-208. https://doi.org/10.1038/onc.2008.373
  45. Morrison, L. E., Jewell, S. S., Usha, L., Blondin, B. A., Rao, R. D., Tabesh, B., Kemper, M., Batus, M. and Coon, J. S. (2007) Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3 and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer 46, 397-405. https://doi.org/10.1002/gcc.20419
  46. Smedley, D., Sidhar, S., Birdsall, S., Bennett, D., Herlyn, M., Cooper, C. and Shipley, J. (2000) Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 28, 121-125. https://doi.org/10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O
  47. Luo, J. H., Ren, B., Keryanov, S., Tseng, G. C., Rao, U. N., Monga, S. P., Strom, S., Demetris, A. J., Nalesnik, M., Yu, Y. P., Ranganathan, S. and Michalopoulos, G. K. (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44, 1012-1024.
  48. Petrovics, G., Zhang, W., Makarem, M., Street, J. P., Connelly, R., Sun, L., Sesterhenn, I. A., Srikantan, V., Moul, J. W. and Srivastava, S. (2004) Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23, 605-611. https://doi.org/10.1038/sj.onc.1207069
  49. Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J. R., Connell, T., Sesterhenn, I. A., Yoshino, K., Buzard, G. S., Mostofi, F. K., McLeod, D. G., Moul, J. W. and Srivastava, S. (2000) PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 12216-12221. https://doi.org/10.1073/pnas.97.22.12216
  50. Braconi, C., Valeri, N., Kogure, T., Gasparini, P., Huang, N., Nuovo, G. J., Terracciano, L., Croce, C. M. and Patel, T. (2011) Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 108, 786-791. https://doi.org/10.1073/pnas.1011098108
  51. Calin, G. A., Liu, C. G., Ferracin, M., Hyslop, T., Spizzo, R., Sevignani, C., Fabbri, M., Cimmino, A., Lee, E. J., Wojcik, S. E., Shimizu, M., Tili, E., Rossi, S., Taccioli, C., Pichiorri, F., Liu, X., Zupo, S., Herlea, V., Gramantieri, L., Lanza, G., Alder, H., Rassenti, L., Volinia, S., Schmittgen, T. D., Kipps, T. J., Negrini, M. and Croce, C. M. (2007) Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229. https://doi.org/10.1016/j.ccr.2007.07.027
  52. Khaitan, D., Dinger, M. E., Mazar, J., Crawford, J., Smith, M. A., Mattick, J. S. and Perera, R. J. (2011) The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 71, 3852-3862. https://doi.org/10.1158/0008-5472.CAN-10-4460
  53. Yu, M., Ohira, M., Li, Y., Niizuma, H., Oo, M. L., Zhu, Y., Ozaki, T., Isogai, E., Nakamura, Y., Koda, T., Oba, S., Yu, B. and Nakagawara, A. (2009) High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int. J. Oncol. 34, 931-938.
  54. Zhu, Y., Yu, M., Li, Z., Kong, C., Bi, J., Li, J. and Gao, Z. (2011) ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion and survival. Urology 77, 510.e1-5. https://doi.org/10.1016/j.urology.2010.09.022
  55. Chung, S., Nakagawa, H., Uemura, M., Piao, L., Ashikawa, K., Hosono, N., Takata, R., Akamatsu, S., Kawaguchi, T., Morizono, T., Tsunoda, T., Daigo, Y., Matsuda, K., Kamatani, N., Nakamura, Y. and Kubo, M. (2011) Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 102, 245-252. https://doi.org/10.1111/j.1349-7006.2010.01737.x
  56. Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A. and Galun, E. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS One 2, e845. https://doi.org/10.1371/journal.pone.0000845
  57. Gabory, A., Ripoche, M. A., Yoshimizu, T. and Dandolo, L. (2006) The H19 gene: regulation and function of a non-coding RNA. Cytogenet. Genome Res. 113, 188-193. https://doi.org/10.1159/000090831
  58. Gejman, R., Ansell, P. J., Zhao, J., Weng, C. and Klibanski, A. (2007) Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742. https://doi.org/10.1074/jbc.M702029200
  59. Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y., Cheunsuchon, P., Louis, D. N. and Klibanski, A. (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 70, 2350-2358. https://doi.org/10.1158/0008-5472.CAN-09-3885
  60. Wang, J., Liu, X., Wu, H., Ni, P., Gu, Z., Qiao, Y., Chen, N., Sun, F. and Fan, Q. (2010) CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38, 5366-5383. https://doi.org/10.1093/nar/gkq285
  61. Panzitt, K., Tschernatsch, M. M., Guelly, C., Moustafa, T., Stradner, M., Strohmaier, H. M., Buck, C. R., Denk, H., Schroeder, R., Trauner, M. and Zatloukal, K. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132, 330-342. https://doi.org/10.1053/j.gastro.2006.08.026
  62. Tomlins, S. A., Aubin, S. M., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S., Williamsen, S., Hodge, P., Meinke, J., Blase, A., Penabella, Y., Day, J. R., Varambally, R., Han, B., Wood, D., Wang, L., Sanda, M. G., Rubin, M. A., Rhodes, D. R., Hollenbeck, B., Sakamoto, K., Silberstein, J. L., Fradet, Y., Amberson, J. B., Meyers, S., Palanisamy, N., Rittenhouse, H., Wei, J. T., Groskopf, J. and Chinnaiyan, A. M. (2011) Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci. Transl. Med. 3, 94ra72. https://doi.org/10.1126/scitranslmed.3001970

Cited by

  1. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma vol.96, pp.28, 2017, https://doi.org/10.1097/MD.0000000000007496
  2. Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead vol.468, pp.6, 2016, https://doi.org/10.1007/s00424-016-1792-y
  3. Long Noncoding RNA Profiles Reveal Three Molecular Subtypes in Glioma vol.20, pp.4, 2014, https://doi.org/10.1111/cns.12220
  4. SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites vol.9, pp.7, 2014, https://doi.org/10.1371/journal.pone.0103851
  5. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis 2017, https://doi.org/10.1016/j.ymthe.2017.06.027
  6. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma vol.36, pp.5, 2015, https://doi.org/10.1007/s13277-014-2969-7
  7. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma vol.48, pp.2, 2016, https://doi.org/10.3892/ijo.2015.3292
  8. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma vol.344, pp.1, 2014, https://doi.org/10.1016/j.canlet.2013.10.021
  9. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-3998-6
  10. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer vol.468, pp.4, 2015, https://doi.org/10.1016/j.bbrc.2015.11.013
  11. Long noncoding RNA HOTAIR involvement in cancer vol.35, pp.10, 2014, https://doi.org/10.1007/s13277-014-2523-7
  12. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer vol.36, pp.9, 2015, https://doi.org/10.1007/s13277-015-3376-4
  13. A role of long noncoding RNAs in carcinogenesis vol.49, pp.4, 2015, https://doi.org/10.1134/S002689331504010X
  14. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer vol.32, pp.6, 2014, https://doi.org/10.3892/or.2014.3518
  15. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma vol.79, 2016, https://doi.org/10.1016/j.biopha.2016.02.032
  16. Characters, functions and clinical perspectives of long non-coding RNAs vol.291, pp.3, 2016, https://doi.org/10.1007/s00438-016-1179-y
  17. Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin vol.16, pp.1, 2015, https://doi.org/10.1186/s13059-014-0570-4
  18. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis vol.37, pp.1, 2016, https://doi.org/10.1007/s13277-015-3843-y
  19. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression 2017, https://doi.org/10.1111/jcmm.13217
  20. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2 vol.396, 2017, https://doi.org/10.1016/j.canlet.2017.03.018
  21. LncRNAs and neoplasia vol.444, 2015, https://doi.org/10.1016/j.cca.2015.02.046
  22. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression vol.20, pp.3, 2017, https://doi.org/10.3233/CBM-170027
  23. Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer 2015, https://doi.org/10.3892/ol.2015.3186
  24. The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer vol.31, pp.11, 2014, https://doi.org/10.1007/s12032-014-0262-7
  25. Focusing on long noncoding RNA dysregulation in gastric cancer vol.36, pp.1, 2015, https://doi.org/10.1007/s13277-014-2894-9
  26. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis vol.16, pp.2, 2016, https://doi.org/10.1586/14737159.2016.1132164
  27. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer vol.36, pp.4, 2015, https://doi.org/10.1007/s13277-014-2850-8
  28. Epigenetic Influences in the Aetiology of Cancers Arising from Breast and Prostate: A Hypothesised Transgenerational Evolution in Chromatin Accessibility vol.2013, 2013, https://doi.org/10.1155/2013/624794
  29. lncRNAtor: a comprehensive resource for functional investigation of long non-coding RNAs vol.30, pp.17, 2014, https://doi.org/10.1093/bioinformatics/btu325
  30. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway vol.79, pp.9-10, 2016, https://doi.org/10.1080/15287394.2016.1176617
  31. Upregulation of long noncoding RNA SPRY4-IT1 correlates with tumor progression and poor prognosis in cervical cancer vol.6, pp.9, 2016, https://doi.org/10.1002/2211-5463.12102
  32. Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma vol.13, pp.3, 2017, https://doi.org/10.3892/etm.2017.4080
  33. Expression Pattern of Long Non-Coding RNAs in Renal Cell Carcinoma Revealed by Microarray vol.9, pp.6, 2014, https://doi.org/10.1371/journal.pone.0099372
  34. Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China vol.36, pp.4, 2015, https://doi.org/10.1007/s13277-014-2912-y
  35. Epigenetics and cervical cancer: from pathogenesis to therapy vol.35, pp.6, 2014, https://doi.org/10.1007/s13277-014-1737-z
  36. Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges vol.18, pp.5, 2016, https://doi.org/10.1007/s12094-015-1404-x
  37. A novel regulatory network among LncRpa, CircRar1, MiR-671 and apoptotic genes promotes lead-induced neuronal cell apoptosis vol.91, pp.4, 2017, https://doi.org/10.1007/s00204-016-1837-1
  38. Overexpression of long non‑coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia 2015, https://doi.org/10.3892/ol.2015.3552
  39. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-014-2807-y
  40. Prognostic value of lncRNA SOX2OT for Chinese cancer patients: A meta-analysis vol.12, pp.5, 2017, https://doi.org/10.1371/journal.pone.0176889
  41. A critical overview of long non-coding RNA in glioma etiology 2016: an update vol.37, pp.11, 2016, https://doi.org/10.1007/s13277-016-5307-4
  42. Potential Biomarkers in Diagnosis of Human Gastric Cancer vol.34, pp.3, 2016, https://doi.org/10.3109/07357907.2015.1114122
  43. Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma vol.56, pp.3, 2015, https://doi.org/10.1007/s12031-014-0488-z
  44. lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma vol.13, pp.6, 2017, https://doi.org/10.3892/ol.2017.6021
  45. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1 vol.119, pp.10, 2018, https://doi.org/10.1002/jcb.26883
  46. Long noncoding RNAs: regulation, function and cancer vol.34, pp.2, 2018, https://doi.org/10.1080/02648725.2018.1471566
  47. Silencing of Long Noncoding RNA SOX21-AS1 Relieves Neuronal Oxidative Stress Injury in Mice with Alzheimer’s Disease by Upregulating FZD3/5 via the Wnt Signaling Pathway pp.1559-1182, 2018, https://doi.org/10.1007/s12035-018-1299-y
  48. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis vol.13, pp.6, 2018, https://doi.org/10.1371/journal.pone.0198602
  49. CRNDE: An important oncogenic long non-coding RNA in human cancers vol.51, pp.3, 2018, https://doi.org/10.1111/cpr.12440